Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Flaherty, PharmD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Innsbruck, Austria
- Facility name not stated
Vienna, Austria
- Facility name not stated
Vienna, Austria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Varna, Bulgaria
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Winnepeg, Manitoba, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Brno, Czechia
- Facility name not stated
Pilsen, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Ústí nad Labem, Czechia
- Facility name not stated
Ulm, Baden-Wurttemberg, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Düsseldorf, Germany
- Facility name not stated
Essen, Germany
- Facility name not stated
Frankfurt, Germany
- Facility name not stated
Hamburg, Germany
- Facility name not stated
Hanover, Germany
- Facility name not stated
Stuttgart, Germany
- Facility name not stated
Larissa, Greece
- Facility name not stated
Pátrai, Greece
- Facility name not stated
Thessaloniki, Greece
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Gyula, Hungary
- Facility name not stated
Kasposvar, Hungary
- Facility name not stated
Auckland, New Zealand
- Facility name not stated
Hamilton, New Zealand
- Facility name not stated
Wellington, New Zealand
- Facility name not stated
Bialystok, Poland
- Facility name not stated
Bydgoszcz, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 30 Nov 2011
- Completion
- 28 Feb 2015
- Last update posted
- 11 Mar 2016
- Registered enrollment
- 280
- Registry id
- NCT00737568
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.